标题
Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review
作者
关键词
-
出版物
ADVANCES IN THERAPY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-02-17
DOI
10.1007/s12325-020-01251-y
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Prophylactic Therapy of Silymarin (Milk Thistle) on Antituberculosis Drug-Induced Liver Injury: A Meta-Analysis of Randomized Controlled Trials
- (2019) Lina Tao et al. Canadian Journal of Gastroenterology and Hepatology
- Oxidative Stress and Antioxidant Biomarkers in Clinical and Experimental Models of Non-Alcoholic Fatty Liver Disease
- (2019) Ayokanmi Ore et al. Medicina-Lithuania
- EASL Clinical Practice Guidelines: Management of alcohol-related liver disease
- (2018) Mark Thursz et al. JOURNAL OF HEPATOLOGY
- The use of SAMe in chemotherapy-induced liver injury
- (2018) B. Vincenzi et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Burden of Liver Diseases in the World
- (2018) Sumeet K. Asrani et al. JOURNAL OF HEPATOLOGY
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- (2017) Naga Chalasani et al. HEPATOLOGY
- The interplay of IKK, NF-κB and RIPK1 signaling in the regulation of cell death, tissue homeostasis and inflammation
- (2017) Vangelis Kondylis et al. IMMUNOLOGICAL REVIEWS
- A vicious circle between insulin resistance and inflammation in nonalcoholic fatty liver disease
- (2017) Zhonge Chen et al. Lipids in Health and Disease
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
- (2016) JOURNAL OF HEPATOLOGY
- A Comprehensive Updated Review of Pharmaceutical and Nonpharmaceutical Treatment for NAFLD
- (2016) Newaz Hossain et al. Gastroenterology Research and Practice
- Protective Role of Sylimarin on Methotrexate induced Hepato-nephrotoxicity in Children with Acute Lymphoblastic Leukemia
- (2016) Adel Abd Elhaleim Hagag Mediterranean Journal of Hematology and Infectious Diseases
- A double-blinded randomized controlled trial of silymarin for the prevention of antituberculosis drug-induced liver injury
- (2015) Chote Luangchosiri et al. BMC Complementary and Alternative Medicine
- The Role of Oxidative Stress and Antioxidants in Liver Diseases
- (2015) Sha Li et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Efficacy of Lifestyle Changes in Subjects with Non-Alcoholic Liver Steatosis and Metabolic Syndrome May Be Improved with an Antioxidant Nutraceutical: A Controlled Clinical Study
- (2015) Gianpaolo Sorrentino et al. Drugs in research & development
- Effect and the probable mechanisms of silibinin in regulating insulin resistance in the liver of rats with non-alcoholic fatty liver
- (2013) Jiayin Yao et al. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- Pathophysiology of NASH: Perspectives for a Targeted Treatment
- (2013) Fabio Marra et al. CURRENT PHARMACEUTICAL DESIGN
- Acute Liver Failure
- (2013) William Bernal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Alterations in Sulfur Amino Acid Metabolism in Mice Treated with Silymarin: A Novel Mechanism of Its Action Involved in Enhancement of the Antioxidant Defense in Liver
- (2013) Do Kwon et al. PLANTA MEDICA
- Current Concepts and Management Approaches in Nonalcoholic Fatty Liver Disease
- (2013) Bashar M. Attar et al. TheScientificWorldJOURNAL
- Glutathione synthesis
- (2012) Shelly C. Lu BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Legalon® SIL: The Antidote of Choice in Patients with Acute Hepatotoxicity from Amatoxin Poisoning
- (2012) Ulrich Mengs et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Identification of novel mechanisms of silymarin on the carbon tetrachloride-induced liver fibrosis in mice by nuclear factor-κB bioluminescent imaging-guided transcriptomic analysis
- (2012) Chia-Cheng Li et al. FOOD AND CHEMICAL TOXICOLOGY
- The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
- (2012) Naga Chalasani et al. HEPATOLOGY
- Silymarin suppresses hepatic stellate cell activation in a dietary rat model of non-alcoholic steatohepatitis: Analysis of isolated hepatic stellate cells
- (2012) MINA KIM et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Amanita phalloidespoisoning
- (2011) Loren Keith French et al. CLINICAL TOXICOLOGY
- Effect of Vitamin E or Metformin for Treatment of Nonalcoholic Fatty Liver Disease in Children and Adolescents
- (2011) Joel E. Lavine JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Role of nuclear factor κB in liver health and disease
- (2010) Stuart M. Robinson et al. CLINICAL SCIENCE
- The Effect of Lifestyle Changes in Non-Alcoholic Fatty Liver Disease
- (2010) Elena Centis et al. DIGESTIVE DISEASES
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
- (2010) Arun J. Sanyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Silymarin suppress CD4+ T cell activation and proliferation: Effects on NF-κB activity and IL-2 production
- (2010) Marjan Gharagozloo et al. PHARMACOLOGICAL RESEARCH
- Milk thistle in liver diseases: past, present, future
- (2010) Ludovico Abenavoli et al. PHYTOTHERAPY RESEARCH
- Oxidative stress and antioxidants in hepatic pathogenesis
- (2010) Hye-Lin Ha WORLD JOURNAL OF GASTROENTEROLOGY
- A randomized, controlled, double-blind, pilot study of milk thistle for the treatment of hepatotoxicity in childhood acute lymphoblastic leukemia (ALL)
- (2009) Elena J. Ladas et al. CANCER
- Alcoholic liver disease
- (2009) Robert S. O'Shea et al. HEPATOLOGY
- Silymarin Ascending Multiple Oral Dosing Phase I Study in Noncirrhotic Patients With Chronic Hepatitis C
- (2009) Roy L. Hawke et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Silybin, a component of sylimarin, exerts anti-inflammatory and anti-fibrogenic effects on human hepatic stellate cells
- (2009) Marco Trappoliere et al. JOURNAL OF HEPATOLOGY
- A randomized controlled trial to assess the safety and efficacy of silymarin on symptoms, signs and biomarkers of acute hepatitis
- (2009) Samer S. El-Kamary et al. PHYTOMEDICINE
- Nuclear factor kappa B and hepatitis viruses
- (2008) Yong-Song Guan et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- NF-κB in liver diseases: a target for drug therapy
- (2008) Pablo Muriel JOURNAL OF APPLIED TOXICOLOGY
- Assessment of drug–drug interaction for silymarin
- (2008) Johannes Doehmer et al. TOXICOLOGY IN VITRO
- An Updated Systematic Review with Meta-Analysis for the Clinical Evidence of Silymarin
- (2008) R. Saller et al. FORSCHENDE KOMPLEMENTARMEDIZIN
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started